Point of Care: growth drivers in an increasingly crowded marketplace

July 8, 2013 - PRLog -- "During 2011, growth in the POC sector, excluding consumer and glucose testing products, is estimated to have been 7%. This growth was driven by the increasing adoption of all types of POC technologies by both professional and self-testing users, as well as the launch of new products and rising demand in emerging markets.
As technology progresses and companies vie for position in an increasingly crowded marketplace, all executives must have a keen appreciation of the drivers and dampeners at play in this important market sector." - Espicom, Point-of-Care Diagnostics Market: Products, Players & Outlook to 2017.

Against this backdrop SMi’s 10th Annual Point of Care: Innovations of the Future conference will bring together a plethora of highly respected speakers to discuss topics ranging from the analysis of how the future of Point of Care testing will look and change over the next decade to how to assist patients with self testing and what alternative approaches are being implemented for patient monitoring.

On this last topic, Trevor Lewis, Principal Consultant at Medical Device Consultancy, world renowned for his knowledge in this field, will discuss how the future of POCD might eventually look and will provide reasons as to why some technologies succeed while others fail and discuss potential gaps in the market for these technologies.

KEY TOPICS:
•Identify key industry trends and market opportunities
•Discover new technological applications and the latest advances in device technology
•Learn how to overcome potential barriers to commercialisation of a new technology
•Gain an insight into the future of POC technologies
•Understand the benefits of non-invasive patient testing and how new profiling technologies lead to a better personalised treatment approach

EXPERT SPEAKERS INCLUDE:
•David Huckle, Chief Executive, Adams Business Associates
•Maurice O’Kane, Consultant Chemical Pathologist /Director for Research and Development, Western Health and Social Care Trust
•Mohammad Al-Ubaydli, CEO, Patients Know Best
•Kavita Oberoi, Founder and Managing Director, Oberoi Consulting
•Gillian Hall, POCT Coordinator, Royal Brompton and Harefield NHS Foundation Trust
•Tony Gibson, Scientific Director, North East Pathology Network Coordinator
•Per Simonsson, Professor of Clinical Chemistry, University Hospital MAS
•Phil Lefebvre, Senior Manager, Business Development, Abbott Laboratories
•Nigel Sansom, Senior Manager, Celaris Biosystems
•Jose Manuel Costa, Associate Professor, University of Oviedo
•Roger Peck, Technical Officer, PATH
•Bernard Branson, Associate Director for Laboratory Diagnostics, Centre for Disease Control
•John Clarkson, CEO, Atlas Genetics
•Brian Winn, Partner, NHS Institute for Innovation and Improvement
•John Rippeth, Principle Consultant, PA Consulting

For the full conference programme and further information please visit: www.smi-online.co.uk/2013pointofcare45.asp

Alternatively contact:  Fateja Begum on +44 20 7827 6184 or email fbegum@smi-online.co.uk

For Sponsorship opportunities please contact: Alia Malick on +44 (0)20 7827 6168 or email amalick@smi-online.co.uk

About SMi Group
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.
For more information, please visit www.smi-online.co.uk